1-11 of 11
Maria Rosaria Ricciardi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Glycolysis and MAPK Pathway: A Combined Pre-Clinical Approach on Acute Myeloid Leukemia

Simone Mirabilii, PhD, Maria Rosaria Ricciardi, PhD, Roberto Licchetta, M.Sc., Maria Paola Bianchi, MD, Monica Piedimonte, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2016) 128 (22): 2751.
https://doi.org/10.1182/blood.V128.22.2751.2751
Published: 2016
Journal Articles

Pre Clinical mTOR-Inhibition of Acute Lymphoblastic Leukemia Cells Synergizes with Pro-Apoptotic Target Therapy Through Mcl-1 Down-Regulation,

Stefano Iacovelli, Maria Rosaria Ricciardi, PhD, Paola Bergamo, Cinzia Rinaldo, PhD, Roberto Licchetta, Antonella Vitale, Anna Testi, MD, Maria Teresa Petrucci, MD, Marina Konopleva, MD, PhD, Michele Milella, MD, Robin Foà, Agostino Tafuri
Journal: Blood
Blood (2011) 118 (21): 3581.
https://doi.org/10.1182/blood.V118.21.3581.3581
Published: 2011
Journal Articles

Bcl-2 and mTOR as Effective Targets for Molecular Therapy of Acute Lymphoblastic Leukemia

Stefano Iacovelli, Maria Rosaria Ricciardi, PhD, Andrea Miele, Paola Bergamo, Roberto Licchetta, Antonella Vitale, MD, Anna Testi, MD, Maria Teresa Petrucci, MD, Michele Milella, MD, Robin Foà, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2010) 116 (21): 3228.
https://doi.org/10.1182/blood.V116.21.3228.3228
Published: 2010
Journal Articles

Novel Histone Deacetilase (HDAC) Inhibitors: In Vitro Effects on Leukemic Cells

Maria Rosaria Ricciardi, PhD, Roberto Licchetta, Paola Bergamo, Stefano Iacovelli, Andrea Miele, Maria Teresa Petrucci, MD, Michele Milella, MD, Claudio Pisano, PhD, Agostino Tafuri, MD
Journal: Blood
Blood (2010) 116 (21): 4946.
https://doi.org/10.1182/blood.V116.21.4946.4946
Published: 2010
Journal Articles

Simultaneous Targeting of Bcl-2/Bcl-Xl and MEK/ERK Results in Highly Synergistic Induction of Apoptosis in Human AML, Both in Vitro and In Vivo.

Marina Konopleva, MD, PhD, Michele Milella, MD, Julie C Watts, PhD, Maria Rosaria Ricciardi, PhD, Borys Korchin, PhD, Twee Tsao, PhD, Paola Bergamo, MS, Duncan H. Mak, PhD, Samantha Decandia, PhD, James McCubrey, PhD, Agostino Tafuri, MD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2757.
https://doi.org/10.1182/blood.V114.22.2757.2757
Published: 2009
Journal Articles

Parallel Signaling through PI3K/AKT/mTOR Mediates Resistance to MEK Inhibition in Preclinical Models of Acute Myeloid Leukemia (AML): Synergistic Effects of Combined MEK and mTOR Inhibition.

Maria Rosaria Ricciardi, PhD, Twee Tsao, PhD, Stephen Lee Abrams, PhD, Paola Bergamo, MS, Linda S Steelman, BS., MS, Samantha Decandia, PhD, Lara Felicioni, PhD, Ludovica Ciuffreda, PhD, Cristina Di Sanza, PhD, Antonio Marchetti, MD, PhD, Francesco Cognetti, MD, James McCubrey, PhD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Agostino Tafuri, MD, Michele Milella, MD
Journal: Blood
Blood (2009) 114 (22): 594.
https://doi.org/10.1182/blood.V114.22.594.594
Published: 2009
Journal Articles

Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)

Maria Rosaria Ricciardi, PhD, Samantha Decandia, Sara Santinelli, Chiara Gregorj, Fabiana De Cave, Maria Cristina Scerpa, PhD, Paola Bergamo, MS, Francesco Libotte, Cinzia De Benedictis, Antonella Vitale, Maria Teresa Petrucci, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Michele Milella, Robert Foa, Agostino Tafuri
Journal: Blood
Blood (2008) 112 (11): 5034.
https://doi.org/10.1182/blood.V112.11.5034.5034
Published: 2008
Journal Articles

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Maria Rosaria Ricciardi, PhD, Chiara Gregorj, PhD, Fabiana De Cave, MS, Paola Bergamo, Samantha Decandia, MS, Sara Santinelli, Antonella Vitale, MD, Maria Teresa Petrucci, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2007) 110 (11): 155.
https://doi.org/10.1182/blood.V110.11.155.155
Published: 2007
Journal Articles

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Maria Rosaria Ricciardi, PhD, Elisabetta Calabrese, MD, Fabiana De Cave, PhD, Sara Santinelli, Paola Bergamo, Samantha Decandia, PhD, Chiara Gregorj, PhD, Vincenzo Federico, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2007) 110 (11): 4782.
https://doi.org/10.1182/blood.V110.11.4782.4782
Published: 2007
Journal Articles

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Fabiana De Cave, MS, Maria Teresa Petrucci, MD, Chiara Gregorj, PhD, Maria Rosaria Ricciardi, PhD, Samantha Decandia, MS, Paola Bergamo, Sara Santinelli, Antonella Vitale, MD, Giorgina Specchia, MD, Francesco Di Raimondo, MD, Andrea Camera, MD, Eugenio Gallo, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Nicola Cascavilla, MD, Francesco Fabbiano, MD, Giuseppe Leone, MD, Omar Perbellini, MD, Patrizio Mazza, MD, Luciana Annino, MD, Piero Galieni, MD, Eustachio Miraglia, MD, Giovanna Meloni, MD, Paola Fazi, MD, PhD, Marco Vignetti, MD, Robert Foa, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2007) 110 (11): 2802.
https://doi.org/10.1182/blood.V110.11.2802.2802
Published: 2007
Journal Articles

Molecular and Functional Effects of the Novel MEK Inhibitor PD0325901 in Preclinical Models of Human Leukemias.

Michele Milella, MD, Maria Rosaria Ricciardi, PhD, Chiara Gregorj, PhD, Fabiana De Cave, PhD, Steven L. Abrams, BS, Linda S. Steelman, MS, Sabina Chiaretti, PhD, Marina Konopleva, MD, PhD, Maria Teresa Petrucci, MD, Francesco Cognetti, MD, Robert Foa, MD, PhD, Michael Andreeff, MD, PhD, James McCubrey, PhD, Agostino Tafuri, MD
Journal: Blood
Blood (2006) 108 (11): 254.
https://doi.org/10.1182/blood.V108.11.254.254
Published: 2006